晚期食管癌化疗临床疗效观察
摘要
我院自2006年7月至2007年7月应用多西紫杉醇联合顺铂(DDP)和5-氟尿嘧啶(5-FU)方案治疗18例晚期食管癌患者,取得较满意疗效,现报道如下。
出处
《国际肿瘤学杂志》
CAS
2008年第10期799-800,共2页
Journal of International Oncology
参考文献5
-
1Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol, 1994, 21 (4) :474-482.
-
2Ilson DH, Ajanl J, Bhalla K, et al. Phase Ⅱ trial of paelitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol, 1998, 16(5) :1826-1834.
-
3Heath EI, Urba S, Marshall J, et al. Phase Ⅱ trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus. J Invest New Drugs, 2002 , 20( 1 ) :95-99.
-
4Muro K, Hamaguchi T, Ohtsu A, et al. A phase Ⅱ study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol,2004 , 15(6):955-959.
-
5Schull B, Komek GV, Sehmid K, et al. Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer. J Oncology, 2003, 65(3 ) :211-21.
-
1马剑,凌扬,杨全良,毕延智.雷替曲塞联合铂类在晚期食管癌化疗中的疗效及安全性[J].现代肿瘤医学,2016,24(8):1207-1209. 被引量:16
-
2李珊珊,裘宋良,郭花芹.食管癌化疗体外药敏试验方法[J].河南肿瘤学杂志,1991,4(2):10-13.
-
3郜娜娜,贺新爱,吕晶晶.养正消积胶囊联合化疗治疗晚期食管癌临床观察[J].医学理论与实践,2014,27(13):1731-1732. 被引量:6
-
4孙爱党.TP方案在食管癌化疗应用中的护理体会[J].中国误诊学杂志,2010,10(20):4975-4975. 被引量:1
-
5崔瑶,刘明月,史祖宣,龚智泉,高天慧.E-cadherin对晚期食管癌化疗有效性的预测作用的研究[J].医药论坛杂志,2016,37(10):4-6.
-
6吴剑,刘卓星.局部晚期食管癌化疗同步调强放疗的疗效观察[J].临床医学工程,2015,22(12):1638-1639. 被引量:1
-
7赵玉林,刘继彦.晚期食管癌姑息性化疗临床研究现状和进展[J].华西医学,2007,22(2):433-434. 被引量:2
-
8刘蒲香,宋恕平,杨锡贵,迟克胜,费凤玲.食管癌化疗近期疗效浅析[J].实用肿瘤学杂志,1991,5(3):52-53.
-
9陈云.贞芪扶正颗粒对食管癌化疗患者生存质量及免疫功能的影响[J].吉林中医药,2015,35(10):1025-1027. 被引量:12
-
10李苏宜.食管癌化疗新进展[J].中国厂矿医学,2007,20(1):2-4.